Search

What do advances in sequencing technology mean for research in cancer genomics?

Improving translational models for inherited retinal diseases

Eva Cuypers discusses the vast potential of MSI, her work in cancer research, and the importance of researcher-clinician relationships

Electrochemistry has almost limitless potential. But collaboration between scientists – especially analytical scientists – will be key.

Sweedler talks shifting authorship geographies, the growth of data science, and developments in single-cell analysis over the past decade

Can digital tools help cell and gene therapy evolve?

Sitting Down With… Russ Algar, Associate Professor, Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada

Why 2023 is the year that antibody manufacturers should embrace CRISPR gene editing.

Graham Cooks discusses the decade’s most exciting developments, where he thinks the field will take us next, and some personal highlights

In the Hurdles and High Jumps series, we asked experienced mentors and industry leaders to address the top challenges you're facing as a translational researcher.